Erik-Jan Kamsteeg

Erik-Jan Kamsteeg

Auto-generated profile, based on publicly available information

Erik-Jan Kamsteeg

Department of Human Genetics Radboud university medical center Nijmegen The Netherlands

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2015 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
MBMaxime G Blanchard
Maxime G Blanchard
MWMarjolein H Willemsen
Marjolein H Willemsen
JWJaclyn B Walker
Jaclyn B Walker
SDSulayman D Dib-Hajj
Sulayman D Dib-Hajj
SWStephen G Waxman
Stephen G Waxman
EKErik-Jan Kamsteeg
Erik-Jan Kamsteeg
Background: Mutations of SCN8A encoding the neuronal voltage-gated sodium channel NaV1.6 are associated with early-infantile epileptic encephalopathy type 13 (EIEE13) and intellectual disability. Using clinical exome sequencing, we have detected three novel de novo SCN8A mutations in patients with intellectual disabilities, and variable clinical features including seizures in two patients. To determine the causality of these SCN8A mutations in the disease of those three patients, we aimed to study the (dys)function of the mutant sodium channels. Methods: The functional consequences of the three SCN8A mutations were assessed using electrophysiological analyses in transfected cells. Genotype–phenotype correlations of these and other cases were related to the functional analyses. Results: The first mutant displayed a 10 mV hyperpolarising shift in voltage dependence of activation (gain of function), the second did not form functional channels (loss of function), while the third mutation was functionally indistinguishable from the wildtype channel. Conclusions: Comparison of the clinical features of these patients with those in the literature suggests that gain-of-function mutations are associated with severe EIEE, while heterozygous loss-of-function mutations cause intellectual disability with or without seizures. These data demonstrate that functional analysis of missense mutations detected by clinical exome sequencing, both inherited and de novo, is valuable for clinical interpretation in the age of massive parallel sequencing.

5 September 2019 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
MPMaartje Pennings
Maartje Pennings
MSMeyke I. Schouten
Meyke I. Schouten
JGJudith van Gaalen
Judith van Gaalen
RMRowdy P. P. Meijer
Rowdy P. P. Meijer
SBSusanne T. de Bot
Susanne T. de Bot
EKErik-Jan Kamsteeg
Erik-Jan Kamsteeg
Variants in the KIF1A gene can cause autosomal recessive spastic paraplegia 30, autosomal recessive hereditary sensory neuropathy, or autosomal (de novo) dominant mental retardation type 9. More recently, variants in KIF1A have also been described in a few cases with autosomal dominant spastic paraplegia. Here, we describe 20 KIF1A variants in 24 patients from a clinical exome sequencing cohort of 347 individuals with a mostly ‘pure’ spastic paraplegia. In these patients, spastic paraplegia was slowly progressive and mostly pure, but with a highly variable disease onset (0–57 years). Segregation analyses showed a de novo occurrence in seven cases, and a dominant inheritance pattern in 11 families. The motor domain of KIF1A is a hotspot for disease causing variants in autosomal dominant spastic paraplegia, similar to mental retardation type 9 and recessive spastic paraplegia type 30. However, unlike these allelic disorders, dominant spastic paraplegia was also caused by loss-of-function variants outside this domain in six families. Finally, three missense variants were outside the motor domain and need further characterization. In conclusion, KIF1A variants are a frequent cause of autosomal dominant spastic paraplegia in our cohort (6–7%). The identification of KIF1A loss-of-function variants suggests haploinsufficiency as a possible mechanism in autosomal dominant spastic paraplegia.

15 March 2022 in Human Mutation
Verified
Journal Article
Open access
JCJordi Corominas
Jordi Corominas
SSSanne P. Smeekens
Sanne P. Smeekens
MNMarcel R. Nelen
Marcel R. Nelen
HYHelger G. Yntema
Helger G. Yntema
EKErik‐Jan Kamsteeg
Erik‐Jan Kamsteeg
CGChristian Gilissen
Christian Gilissen
Massive parallel sequencing technology has become the predominant technique for genetic diagnostics and research. Many genetic laboratories have wrestled with the challenges of setting up genetic testing workflows based on a completely new technology. The learning curve we went through as a laboratory was accompanied by growing pains while we gained new knowledge and expertise. Here we discuss some important mistakes that have been made in our laboratory through 10 years of clinical exome sequencing but that have given us important new insights on how to adapt our working methods. We provide these examples and the lessons that we learned to help other laboratories avoid to make the same mistakes.

25 September 2020 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
NKNick Kruijt
Nick Kruijt
LBL.R. van den Bersselaar
L.R. van den Bersselaar
EKE. J. Kamsteeg
E. J. Kamsteeg
WVW. Verbeeck
W. Verbeeck
MSM. M. J. Snoeck
M. M. J. Snoeck
NVNicol Voermans
Nicol Voermans
Background and purpose: Rhabdomyolysis is a medical emergency characterized by acute skeletal muscle breakdown with a sudden rise and subsequent fall of serum creatine kinase (CK) levels. Rhabdomyolysis events are provoked by exposure to external triggers, possibly in combination with an increased genetic susceptibility. We aimed to describe comprehensively the external triggers and potentially pathogenic genetic variants possibly implicated in increased rhabdomyolysis susceptibility.Methods: We performed a retrospective single‐center study, including a total of 1302 patients with an acute CK level exceeding 2000 IU/l.Results: Anoxia was the most frequently reported trigger (40%). A subset of 193 patients were clinically suspected of an underlying genetic disorder (recurrent episodes, a positive family history, very high or persistently increased CK levels). In 72 of these patients, an unequivocal genetic defect was identified. A total of 22 genes with pathogenic variants were identified, including 52 different variants. Of those, 11 genes have been previously associated with rhabdomyolysis (ACADVL, ANO5, CPT2, DMD, DYSF, FKRP, HADHA, PGM1, LPIN1, PYGM, RYR1). Eleven genes are probably implicated in increased susceptibility (including AGL, CAPN3, CNBP, DMPK, MAGT1, ACADM, SCN4A, SGCA, SGCG, SMPD1, TANGO2).Conclusion: These findings suggest that the spectrum of genetic susceptibility for rhabdomyolysis has not yet been completely clarified. With the increasing availability of next‐generation sequencing in a diagnostic setting, we expect that in more cases a genetic defect will be identified.

1 August 2021 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
BSBart P.G.H. van der Sanden
Bart P.G.H. van der Sanden
JCJordi Corominas
Jordi Corominas
MGMichelle de Groot
Michelle de Groot
MPMaartje Pennings
Maartje Pennings
RMRowdy P.P. Meijer
Rowdy P.P. Meijer
CGChristian Gilissen
Christian Gilissen

3 August 2020 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
ASAnne Slavotinek
Anne Slavotinek
DMDoriana Misceo
Doriana Misceo
SHStephanie Htun
Stephanie Htun
LMLinda Mathisen
Linda Mathisen
EFEirik Frengen
Eirik Frengen
ACAnita H Corbett
Anita H Corbett
The RNA exosome is an essential ribonuclease complex required for processing and/or degradation of both coding and non-coding RNAs. We identified five patients with biallelic variants in EXOSC5, which encodes a structural subunit of the RNA exosome. The clinical features of these patients include failure to thrive, short stature, feeding difficulties, developmental delays that affect motor skills, hypotonia and esotropia. Brain MRI revealed cerebellar hypoplasia and ventriculomegaly. While we ascertained five patients, three patients with distinct variants of EXOSC5 were studied in detail. The first patient had a deletion involving exons 5–6 of EXOSC5 and a missense variant, p.Thr114Ile, that were inherited in trans, the second patient was homozygous for p.Leu206His and the third patient had paternal isodisomy for chromosome 19 and was homozygous for p.Met148Thr. The additional two patients ascertained are siblings who had an early frameshift mutation in EXOSC5 and the p.Thr114Ile missense variant that were inherited in trans. We employed three complementary approaches to explore the requirement for EXOSC5 in brain development and assess consequences of pathogenic EXOSC5 variants. Loss of function for exosc5 in zebrafish results in shortened and curved tails/bodies, reduced eye/head size and edema. We modeled pathogenic EXOSC5 variants in both budding yeast and mammalian cells. Some of these variants cause defects in RNA exosome function as well as altered interactions with other RNA exosome subunits. These findings expand the number of genes encoding RNA exosome subunits linked to human disease while also suggesting that disease mechanism varies depending on the specific pathogenic variant.